09/07/2010
Skin Cancer Linked To Warts Infection
Suffering the virus that causes warts and verrucas can increase the risk of certain cancers.
An international team of researchers has found that people with several types of the virus - human papillomaviruses (HPVs) - were more than one and a half times as likely to develop certain skin cancers compared to people with no HPVs.
While it is common - with most people having the virus at some time in their lives - it has been shown that HPV infection heightens the risk of developing the skin cancers, the risk being worsened if people are taking immunosuppression drugs.
That's according to a new study published on the British Medical Journal's website, bmj.com today.
The most common skin cancers (basal cell carcinoma and squamous cell carcinoma) are increasing globally and ultraviolet radiation is the main established risk factor.
In addition, HPV infection - of which there are more than 100 types - may play a role in their development.
Other types of HPVs are known to cause cancers of the cervix, vulva, vagina, anus, and penis.
Research so far has identified increased risks for people with skin HPV types called beta HPVs, particularly among organ transplant recipients and people with epidermodysplasia verruciformis (EV) – a rare genetic disorder, which leads to warts and malignant skin lesions.
Now researchers, led by Professor Margaret Karagas of the Dartmouth Medical School in the USA, wanted to find more conclusive evidence of a link between beta HPVs and the common skin cancers among the general population.
They studied 2,366 people living in New Hampshire, USA, made up of 663 people with squamous cell carcinoma, 898 people with basal cell carcinoma and 805 healthy controls.
As well as interviewing the study participants, the researchers measured HPV antibodies in blood samples of newly diagnosed and confirmed basal cell and squamous cell carcinoma patients from two periods - July 1993 to June 1995 and July 1997 to March 2000 and matched population controls.
Results showed that people with squamous cell carcinoma, but not basal cell carcinoma, were far more likely to have each of the beta HPV types compared to people in the control group. The likelihood of having squamous cell carcinoma increased as people were found to have more of the HPV types.
For example, people with squamous cell carcinoma were 1.4 times more likely to have two to three types of HPV, and 1.7 times more likely to have greater than eight types of HPV compared with the control group.
The researchers also found that people who were long term users of immunosuppressant drugs had more than a three-fold risk of squamous cell carcinoma in relation to HPV, but with limited statistical precision.
"Given the widespread and growing occurrence of these malignancies, our results raise the possibility of reducing the health and economic burden of these cancers through prevention or treatment of human papillomavirus infection," concluded the authors.
(BMcC/KMcA)
An international team of researchers has found that people with several types of the virus - human papillomaviruses (HPVs) - were more than one and a half times as likely to develop certain skin cancers compared to people with no HPVs.
While it is common - with most people having the virus at some time in their lives - it has been shown that HPV infection heightens the risk of developing the skin cancers, the risk being worsened if people are taking immunosuppression drugs.
That's according to a new study published on the British Medical Journal's website, bmj.com today.
The most common skin cancers (basal cell carcinoma and squamous cell carcinoma) are increasing globally and ultraviolet radiation is the main established risk factor.
In addition, HPV infection - of which there are more than 100 types - may play a role in their development.
Other types of HPVs are known to cause cancers of the cervix, vulva, vagina, anus, and penis.
Research so far has identified increased risks for people with skin HPV types called beta HPVs, particularly among organ transplant recipients and people with epidermodysplasia verruciformis (EV) – a rare genetic disorder, which leads to warts and malignant skin lesions.
Now researchers, led by Professor Margaret Karagas of the Dartmouth Medical School in the USA, wanted to find more conclusive evidence of a link between beta HPVs and the common skin cancers among the general population.
They studied 2,366 people living in New Hampshire, USA, made up of 663 people with squamous cell carcinoma, 898 people with basal cell carcinoma and 805 healthy controls.
As well as interviewing the study participants, the researchers measured HPV antibodies in blood samples of newly diagnosed and confirmed basal cell and squamous cell carcinoma patients from two periods - July 1993 to June 1995 and July 1997 to March 2000 and matched population controls.
Results showed that people with squamous cell carcinoma, but not basal cell carcinoma, were far more likely to have each of the beta HPV types compared to people in the control group. The likelihood of having squamous cell carcinoma increased as people were found to have more of the HPV types.
For example, people with squamous cell carcinoma were 1.4 times more likely to have two to three types of HPV, and 1.7 times more likely to have greater than eight types of HPV compared with the control group.
The researchers also found that people who were long term users of immunosuppressant drugs had more than a three-fold risk of squamous cell carcinoma in relation to HPV, but with limited statistical precision.
"Given the widespread and growing occurrence of these malignancies, our results raise the possibility of reducing the health and economic burden of these cancers through prevention or treatment of human papillomavirus infection," concluded the authors.
(BMcC/KMcA)
Related UK National News Stories
Click here for the latest headlines.
02 December 2005
Government pledges cash for stem cell research
The government has announced that an extra £50 million will be made available for UK stem cell research over the next two years. The announcement followed the publication of the UK Stem Cell Initiative report, which has recommended that that the government should invest at least £350 million in the research over the next decade.
Government pledges cash for stem cell research
The government has announced that an extra £50 million will be made available for UK stem cell research over the next two years. The announcement followed the publication of the UK Stem Cell Initiative report, which has recommended that that the government should invest at least £350 million in the research over the next decade.
20 March 2012
Hairdressers Could Receive Skin Cancer Training
Hairdressers can and should be trained to check their clients for skin cancer, say health experts. There is currently no general screening for skin cancer in the UK and despite estimates that almost 100,000 new cases of are detected each year, many cases can go undetected for years.
Hairdressers Could Receive Skin Cancer Training
Hairdressers can and should be trained to check their clients for skin cancer, say health experts. There is currently no general screening for skin cancer in the UK and despite estimates that almost 100,000 new cases of are detected each year, many cases can go undetected for years.
18 January 2012
Govt Launches Hydrogen Car Project
The Government has announced a project to ready the UK for hydrogen fuel vehicles starting in 2014.
Govt Launches Hydrogen Car Project
The Government has announced a project to ready the UK for hydrogen fuel vehicles starting in 2014.
19 October 2011
Ruling Could Stop Euro Stem Cell Research – Scientists
Stem-cell scientists in Europe are reeling from a ruling on Wednesday banning patents on stem cells obtained through the destruction of human embryos. The decision by the European Court of Justice means that no European patents will be given for research based on stem cells extracted from anything capable of developing into a human being.
Ruling Could Stop Euro Stem Cell Research – Scientists
Stem-cell scientists in Europe are reeling from a ruling on Wednesday banning patents on stem cells obtained through the destruction of human embryos. The decision by the European Court of Justice means that no European patents will be given for research based on stem cells extracted from anything capable of developing into a human being.
19 May 2008
MP's To Vote On Human-Animal Embryo Research
The Commons is to vote on controversial plans for research to be carried out using human-animal embryos today which could mark a turning point in medicine. Prime Minister Gordon Brown is backing the measures saying it could save "millions of lives".
MP's To Vote On Human-Animal Embryo Research
The Commons is to vote on controversial plans for research to be carried out using human-animal embryos today which could mark a turning point in medicine. Prime Minister Gordon Brown is backing the measures saying it could save "millions of lives".